Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127844591 | 12784459 | 1 | I | 20160728 | 20160923 | 20160927 | 20160927 | EXP | FR-AFSSAPS-T020161904 | FR-009507513-1609FRA012393 | MERCK | 28.57 | YR | F | Y | 0.00000 | 20160927 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127844591 | 12784459 | 1 | PS | ISENTRESS | RALTEGRAVIR POTASSIUM | 1 | Oral | 2 DF(1 DF, 2 PER DAY) | 82 | DF | N | 22145 | 1 | DF | TABLET | BID | |||
| 127844591 | 12784459 | 2 | SS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 1 DF (1DF, 1 PER DAY) | 41 | DF | N | 0 | 1 | DF | FILM-COATED TABLET | QD | |||
| 127844591 | 12784459 | 3 | SS | RIFATER | ISONIAZIDPYRAZINAMIDERIFAMPIN | 1 | Oral | 4 DF (4 DF, 1 PER DAY) | 228 | DF | N | 0 | 4 | DF | QD | ||||
| 127844591 | 12784459 | 4 | SS | ETHAMBUTOL | ETHAMBUTOL HYDROCHLORIDE | 1 | Oral | 2 DF(4 DF, BID) | 456 | DF | N | 0 | 4 | DF | FILM-COATED TABLET | BID | |||
| 127844591 | 12784459 | 5 | C | LEDERFOLINE | LEUCOVORIN CALCIUM | 1 | Oral | 1 DF( 1 DF, 1PER DAY) | 0 | 1 | DF | TABLET | QD | ||||||
| 127844591 | 12784459 | 6 | C | BECILAN | PYRIDOXINE | 1 | Oral | 1 DF (1DF, 1 PER DAY) | 0 | 1 | DF | SCORED TABLET | QD | ||||||
| 127844591 | 12784459 | 7 | C | ATARAX | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | Oral | 1 DF (1DF, 1 PER DAY) | 0 | 1 | DF | SCORED TABLET | QD | ||||||
| 127844591 | 12784459 | 8 | C | DEXERYL CREAM | GLYCERINPARAFFIN | 1 | Cutaneous | 1 DF (1DF, 1PER DAY) | 0 | 1 | DF | QD | |||||||
| 127844591 | 12784459 | 9 | C | PENTACARINAT | PENTAMIDINE ISETHIONATE | 1 | Respiratory (inhalation) | 0,0333 DF(1 DF AEROSOL, 1PER MONTH) | 0 | 1 | DF | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127844591 | 12784459 | 1 | HIV infection |
| 127844591 | 12784459 | 2 | HIV infection |
| 127844591 | 12784459 | 3 | Tuberculosis |
| 127844591 | 12784459 | 4 | Tuberculosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127844591 | 12784459 | HO |
| 127844591 | 12784459 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127844591 | 12784459 | Glycosuria | |
| 127844591 | 12784459 | Haematuria | |
| 127844591 | 12784459 | Proteinuria | |
| 127844591 | 12784459 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127844591 | 12784459 | 1 | 20160618 | 20160729 | 0 | |
| 127844591 | 12784459 | 2 | 20160618 | 20160729 | 0 | |
| 127844591 | 12784459 | 3 | 20160602 | 20160729 | 0 | |
| 127844591 | 12784459 | 4 | 20160602 | 20160729 | 0 | |
| 127844591 | 12784459 | 5 | 20160602 | 0 | ||
| 127844591 | 12784459 | 6 | 20160602 | 0 | ||
| 127844591 | 12784459 | 7 | 20160602 | 0 | ||
| 127844591 | 12784459 | 8 | 20160602 | 0 | ||
| 127844591 | 12784459 | 9 | 20160721 | 0 |